Researchers Submit Patent Application, "Vaccines For In Vivo Expression Of Nucleic Acids And Methods Of Using The Same", for Approval (USPTO 20250009875).

The patent application by Thomas E. Wagner and Orbis Health Solutions LLC focuses on developing nucleic acid vaccines to treat or prevent infectious diseases caused by viruses, bacteria, or other microbes, with a specific emphasis on addressing the global public health threat posed by COVID-19. The vaccine platforms described in the application aim to efficiently deliver nucleic acids to antigen presenting cells, inducing a robust immune response to immunogenic peptides encoded by the nucleic acids. By utilizing yeast cell wall particles, lysosome-evading components, and nucleic acid sequences encoding immunogenic peptides, the vaccines seek to stimulate the immune system and prevent infectious diseases like COVID-19. [Extracted from the article]